Navigation Links
NutraCea Names James C. Lintzenich As Interim CEO
Date:3/10/2009

Announces Resignation of Brad Edson

PHOENIX, March 10 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a world leader in stabilized rice bran (SRB) nutrient research and technology, announced today that James C. Lintzenich, chairman of the Audit Committee has been appointed to the role of Chief Executive Officer on an interim basis. Mr. Lintzenich will replace Brad Edson, who has resigned from his positions with the Company as President, CEO and a member of its Board of Directors effective immediately.

Mr. Edson will serve as a consultant to NutraCea as requested by Mr. Lintzenich and the Board of Directors during a transition period for up to two months following Mr. Lintzenich's appointment. NutraCea has commenced a formal search to identify a permanent Chief Executive Officer.

Mr. Lintzenich has been a member of NutraCea's Board of Directors since October 2005 and as a director of The RiceX Company, one of NutraCea's subsidiaries, since June 2003. He is currently overseeing the previously announced review initiated by the Audit Committee of the Board of Directors and the expected financial restatements for the year ended December 31, 2007, including the associated second, third and fourth quarters in 2007, and all of the quarters in 2008. Previously, Mr. Lintzenich was President and Chief Operating Officer of Sallie Mae, a leading provider of student loans in the U.S. He also served as Chief Executive Officer, Chief Operating Officer and Chief Financial Officer of USA Group, Inc., a leading student loan company.

Mr. Lintzenich, commented, "Our immediate, short-term focus is to conclude the Audit Committee's internal review of the accounting matters, complete the previously announced restatements expeditiously and resume normalized communications with our shareholders as quickly as possible.

"While we work through these near-term challenges, I will work with our entire organization to both take advantage of, and prioritize, market opportunities for NutraCea as well as to develop a strategic plan and direction for our Company. I will also be leading our efforts to identify and retain a high quality, experienced CEO with a good balance of leadership and food manufacturing experience."

David Bensol, Chairman of the Board, stated, "We are pleased that Jim has agreed to assume the role of interim CEO; his extensive corporate experience will serve NutraCea well until a full-time candidate is identified. We remain committed to maximizing the Company's long-term growth opportunities and shareholder value."

About NutraCea

NutraCea is a world leader in production and utilization of stabilized rice bran. NutraCea holds many patents for stabilized rice bran production technology and proprietary neutraceutical formulas ranging from arthritis, chronic bowel conditions, and effective diabetes control to cardiovascular disease treatment protocols. NutraCea's proprietary technology enables the creation of food and nutrition products to be unlocked from rice bran, normally a waste by-product of standard rice processing. Committed to helping the underfed, they're heavily involved in providing product and technology for developing countries through NutraCea's RiceAde feeding program. More information can be found in the Company's filings with the SEC, and you can visit the NutraCea Web site http://www.NutraCea.com

Forward-Looking Statements

This release contains forward-looking statements. These statements are made based upon current expectations and actual results may differ from those projected, due to various risks and uncertainties. NutraCea does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in NutraCea's filings with the Securities and Exchange Commission, including NutraCea's most recent periodic reports.


'/>"/>
SOURCE NutraCea
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NutraCea to Restate Financial Statements for 2007 and 2008
2. NutraCea, FedEx and Feed The Children Team Up to Provide Food Aid to Families in Need in Brazil
3. NutraCea Announces Third Quarter 2008 Financial Results
4. NutraCea Announces Third Quarter 2008 Conference Call
5. Mike Bridges Takes Home Four Gold Medals at IPF Masters World Powerlifting Championships; Says NutraCeas RiSolubles(R) is an Essential Part of his Training Regimen
6. U.S. Chamber Recognizes NutraCea for Strong Corporate Stewardship
7. NutraCea Announces First Quarter 2008 Financial Results
8. NutraCea to Host First Quarter 2008 Conference Call on May 12.
9. NutraCea Announces $20 Million Securities Offering
10. Demand for NutraCea Rice Bran Oil Prompts Major Expansion of Irgovel Plant Ahead of Schedule
11. NutraCea-Sponsored Study Demonstrates Benefits of Replacing Wheat Flour with Stabilized Rice Bran (SRB) in Battered and Fried Product Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... The number of chronically ... aging – meaning that there is an urgent need for highly skilled care managers ... solution, delivering a multi-pronged approach to train and retain care managers, and enhance their ...
(Date:4/28/2016)... ... ... offering a special deal on its webstore. , Buy 1 product and get ANYTHING (including ... with lesser value. In addition, a free bonus of 3 top serums in a ... many women (men, too) love our products and get good results. We want to introduce ...
(Date:4/28/2016)... Oaks, CA (PRWEB) , ... April 28, 2016 , ... ... is currently number one in Central America and is looking to grow their market ... marketing for such an exceptional brand as La Sirena Foods and indirectly ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ... a new CDISC standard, Clinical Trial Registry (CTR) XML. Clinical trial registries ... will make it possible to build applications that generate submissions for multiple, ...
(Date:4/28/2016)... West Palm Beach, FL (PRWEB) , ... April 28, 2016 , ... ... time for the spring season. Smart pots are frequently used by professional organic farmers ... time for growers to order their supply of fabric pots. Our goal is to ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... 2016  ValGenesis, Inc., the market leader ... today announced that a prominent world provider ... chronic kidney failure has selected ValGenesis Validation ... validation process. The global medical device manufacturer ... manage their validation processes electronically. Upon completion ...
(Date:4/27/2016)... BASEL , Schweiz, April 27, 2016 ... des Sachs CEO Forums in Zürich ... Phase-II-Studie ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung ... (CI) eingesetzt wurde, bekannt. Für die umfassende ... Deutschland und Frankreich angeworben. STR001 wird während ...
Breaking Medicine Technology: